MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 197 filers reported holding MYRIAD GENETICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,130 | -52.9% | 70,472 | -31.8% | 0.01% | -62.1% |
| Q1 2023 | $2,399 | +342.6% | 103,309 | +176.3% | 0.03% | +262.5% |
| Q4 2022 | $542 | -99.9% | 37,393 | -10.6% | 0.01% | 0.0% |
| Q1 2022 | $1,053,000 | +88.7% | 41,813 | +48.1% | 0.01% | -27.3% |
| Q4 2020 | $558,000 | +9.8% | 28,227 | -27.7% | 0.01% | -26.7% |
| Q3 2020 | $508,000 | – | 39,024 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |